U.S. flag

An official website of the United States government

NM_001384474.1(LOXHD1):c.4526G>A (p.Gly1509Glu) AND not specified

Germline classification:
Benign (2 submissions)
Last evaluated:
Sep 12, 2016
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000155366.9

Allele description [Variation Report for NM_001384474.1(LOXHD1):c.4526G>A (p.Gly1509Glu)]

NM_001384474.1(LOXHD1):c.4526G>A (p.Gly1509Glu)

Gene:
LOXHD1:lipoxygenase homology PLAT domains 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18q21.1
Genomic location:
Preferred name:
NM_001384474.1(LOXHD1):c.4526G>A (p.Gly1509Glu)
HGVS:
  • NC_000018.10:g.46529181C>T
  • NG_016646.2:g.132853G>A
  • NM_001145472.3:c.1193G>A
  • NM_001308013.2:c.905G>A
  • NM_001384474.1:c.4526G>AMANE SELECT
  • NM_144612.7:c.4526G>A
  • NP_001138944.1:p.Gly398Glu
  • NP_001294942.1:p.Gly302Glu
  • NP_001371403.1:p.Gly1509Glu
  • NP_653213.6:p.Gly1509Glu
  • NP_653213.6:p.Gly1509Glu
  • NC_000018.9:g.44109144C>T
  • NM_144612.6:c.4526G>A
Protein change:
G1509E
Links:
dbSNP: rs187587197
NCBI 1000 Genomes Browser:
rs187587197
Molecular consequence:
  • NM_001145472.3:c.1193G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001308013.2:c.905G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001384474.1:c.4526G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_144612.7:c.4526G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
10

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000205053Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Benign
(Feb 7, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000345467Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Benign
(Sep 12, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown2not providednot providednot providednot providedclinical testing
not providedgermlinenot provided1210not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000205053.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided12not providednot providedclinical testing PubMed (1)

Description

p.Gly1509Glu in exon 29 of LOXHD1: This variant is not expected to have clinical significance because it has been identified in 5% (80/1614) of Finnish chromoso mes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; d bSNP rs187587197).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided12not provided10not provided

From Eurofins Ntd Llc (ga), SCV000345467.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided2not providednot providednot provided

Last Updated: Aug 4, 2024